Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ERN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC30A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF658 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM30A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PPP1R1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC38A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927263 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC00865 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPAR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC71L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM71B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MS4A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VMA21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on